Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies

Jill A Ohar,1 Alyssa Bowling,2 Thomas Goodin,2 Barry Price,2 Ayca Ozol-Godfrey,2 Sanjay Sharma,2 Shahin Sanjar2 1Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA; 2Sunovion Pharmaceuticals Inc, Marlborough, MA, USA Purpose: Bronchodilator reversibility has be...

Full description

Bibliographic Details
Main Authors: Ohar JA, Bowling A, Goodin T, Price B, Ozol-Godfrey A, Sharma S, Sanjar S
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:International Journal of COPD
Subjects:
bronchodilator
COPD
nebulized glycopyrrolate
reversibility
Online Access:https://www.dovepress.com/efficacy-and-safety-of-glycopyrrolate-in-patients-with-copd-by-rever-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/efficacy-and-safety-of-glycopyrrolate-in-patients-with-copd-by-rever-peer-reviewed-article-COPD

Similar Items